Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

894 public trials 110 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Recruiting

Avo In R/R And Previously Untreated MCL

NCT04855695

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

NCT04223765

Conditions
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT06022029

Conditions
Bites and Stings, Bladder Cancer, Breast Diseases, +72 more
Locations
  • California Research Institute Los Angeles, California, United States
  • BRCR Global Tamarac, Florida, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma

NCT07285590

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Instituto Português de Oncologia de Lisboa Francisco Gentil Lisbon, Lisbon District, Portugal
  • Unidade Local De Saude De Santa Maria E.P.E. Lisbon, Lisbon District, Portugal
  • INSTITUT CATALÀ D'ONCOLOGIA (ICO). Hospital Germans Trias I Pujol. Badalona, Barcelona, Spain
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
View all 16 locations
View Trial Details
Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

NCT05602363

Conditions
B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
Locations
  • UC Irvine Health Orange, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 13 locations
View Trial Details

Related conditions